Intermittent Fasting and a No-Sugar Diet for Long COVID Symptoms
Part of paid clinical trials in Boulder, Colorado.
- Sponsor
- Pacific Northwest University of Health Sciences
- Study ID
- NCT06214455
- Status
- Completed
Conditions
- Long COVID
- Long Covid19
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - 69 Years
- Healthy Volunteers
- Not accepted
Interventions
- Low sugar diet and 10-12 hour eating window — OTHERLow sugar diet and 10-12 hour eating window for four weeks
- Low sugar diet, 8 hour eating window and fasting — OTHERLow sugar diet, 8 hour eating window and a 36-60 hour fast once per week for four weeks.
Study Details
This cross-over study will assess a no added sugar diet, a restricted daily eating window, and one or two full day water fasts to determine if there is an effect on self-reported symptoms of Long Covid (PASC).
Key Dates
- Start date
- Nov 4, 2022
- Status verified
- Apr 2026
- Primary completion
- Jul 1, 2024
- Completion
- Sep 10, 2024
Study Design
- Enrollment
- 77 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: 10-12 hour daily Time-Restricted Eating (4 weeks)In this crossover trial, half the participants did the 10-hour TRE first (treatment A), half did it last. A no added sugar diet was suggested for the entire study.
- Experimental: 8-hour TRE, weekly 23 to 60 hour fast (4 weeks)Eating in an 8-hour window daily, with one 23-60 hour fast per week. A no-added sugar diet was suggested.
Primary Outcome Measure
Change in LC-Score, Per Treatment [ Time Frame: Before and after 4 weeks of Fasting treatment or TRE treatment ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Remote trial - anyone residing in the United States | Boulder | Colorado | 80303 | - |
| Pacific Northwest University | Yakima | Washington | 98901 | - |
Find similar trials in Boulder, CO
By condition
By specialty
Related Studies
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVIDPHASE3 · Recruiting · Wes Ely · Tucson, Arizona
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia SyndromeRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19Recruiting · University of California, San Francisco · San Francisco, California